MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 13 - per page Next page
Order by
This TACE inhibitory protein could be used as a new therapeutic agent against chronic inflammatory diseases that are mediated by TNF-alpha. More
Biomarker and possible therapeutic target for a variety of neurodegenerative diseases More
Biologically active compounds inhibiting calpain proteases with potential use for the treatment of acute conditions (e.g. ischemia) and degenerative diseases (particularly neurodegenerative diseases) More
Methods and formulations for treating or preventing Vascular Cognitive Impairment (VCI) through mucosal administration of E-selectin, an inducible adhesion molecule on endothelial cells More
Methods for administering an Eap agent in an amount that will treat or prevent autoimmune neuroinflammatory diseases such as multiple sclerosis, decrease the infiltration of immune cells to the CNS, and inhibit T cell-endothelial cell interactions. More
Biosimilar to Avonex®; available in bulk or finished More
A method and composition for inhibiting or treating symptoms of inflammatory demyelination or inflammation associated with autoimmune disorders. More
Provision of access to DNA samples of 16 common diseases to conduct association studies of specific single nucleotide polymorphisms (SNPs) and specific diseases More
Tissue. Civil: Treatment of inflammatory related diseases: Multiple Sclerosis, Rheumatoid Arthritis etc., Treatment of Sepsis, Treatment of Thermal Burns. Keywords 'MS', 'RA'autoimmune, 'MS' More
The use of an amphipathic weak base having defined characteristics for the preparation of a pharmaceutical formulation for the treatment or prevention of neurodegenerative conditions. keywords: liposomes More
Displaying 1..10 of 13 - per page Next page
Order by

Your selection

Therapeutic target
Central Nervous System del
Neurodegenerative disorders del
Multiple sclerosis del

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us